Occludin, Claudin-1, and ZO-1 expression were upregulated in the AH group compared to the AD group by 165.2%, 45.1%, and 97.9%, respectively (p < 0.001) (Figure 2E–H). Here, OCLN is linked to Alzheimer disease.